Jump to content

Main menu Navigation ●Main page ●Contents ●Current events ●Random article ●About Wikipedia ●Contact us ●Donate Contribute ●Help ●Learn to edit ●Community portal ●Recent changes ●Upload file

●Create account ●Log in ●Create account ● Log in Pages for logged out editors learn more ●Contributions ●Talk

(Top) 1 References 2 External links

2,3,4,5-Tetramethoxyamphetamine

●Српски / srpski ●Srpskohrvatski / српскохрватски Edit links ●Article ●Talk ●Read ●Edit ●View history Tools Actions ●Read ●Edit ●View history General ●What links here ●Related changes ●Upload file ●Special pages ●Permanent link ●Page information ●Cite this page ●Get shortened URL ●Download QR code ●Wikidata item Print/export ●Download as PDF ●Printable version In other projects ●Wikimedia Commons Appearance From Wikipedia, the free encyclopedia (Redirected from Tetramethoxyamphetamine)

2,3,4,5-Tetramethoxyamphetamine
Legal status

Legal status	CA: Schedule I UK: Class A
Identifiers
IUPAC name 1-(2,3,4,5-tetramethoxyphenyl)propan-2-amine
CAS Number	23693-26-7
PubChem CID	44350147
ChemSpider	23206528^Y
UNII	W39F9G7WET
ChEMBL	ChEMBL124969^Y
CompTox Dashboard (EPA)	DTXSID601027160
Chemical and physical data
Formula	C₁₃H₂₁NO₄
Molar mass	255.314 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CC(Cc1cc(c(c(c1OC)OC)OC)OC)N
InChI InChI=1S/C13H21NO4/c1-8(14)6-9-7-10(15-2)12(17-4)13(18-5)11(9)16-3/h7-8H,6,14H2,1-5H3^Y Key:WVNJEHORYAZBRZ-UHFFFAOYSA-N^Y
(verify)

Tetramethoxyamphetamine, or 2,3,4,5-tetramethoxy amphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. Tetramethoxyamphetamine was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 50 mg, and the duration unknown. Tetramethoxyamphetamine produces a threshold, mydriasis, and a headache. Limited data exists about its pharmacological properties, metabolism, and toxicity.^[1]^[2]^[3]

References[edit]

^ Kier LB, Hall LH (December 1977). "Structure-activity studies on hallucinogenic amphetamines using molecular connectivity". Journal of Medicinal Chemistry. 20 (12): 1631–6. doi:10.1021/jm00222a019. PMID 592329.

^ Clare BW (February 1990). "Structure-activity correlations for psychotomimetics. 1. Phenylalkylamines: electronic, volume, and hydrophobicity parameters". Journal of Medicinal Chemistry. 33 (2): 687–702. doi:10.1021/jm00164a036. PMID 2299636.

^ Clare BW (September 1998). "The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens". Journal of Medicinal Chemistry. 41 (20): 3845–56. doi:10.1021/jm980144c. PMID 9748359.

External links[edit]

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=2,3,4,5-Tetramethoxyamphetamine&oldid=1212992637" Categories: ●Substituted amphetamines ●Methoxy compounds ●Psychoactive drug stubs Hidden categories: ●Articles with short description ●Short description matches Wikidata ●Chemical pages without DrugBank identifier ●Articles without KEGG source ●Drugs missing an ATC code ●All stub articles ●This page was last edited on 10 March 2024, at 15:15 (UTC). ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization. ●Privacy policy ●About Wikipedia ●Disclaimers ●Contact Wikipedia ●Code of Conduct ●Developers ●Statistics ●Cookie statement ●Mobile view